Carna Biosciences Revenue

Biotechnology Research • 1-5-5, Minatojima-Minamimachi, Japan • 21-50 Employees

Carna Biosciences revenue & valuation

Annual revenue	$19,400,000
Revenue per employee	$776,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$62,100,000
Total funding	No funding

Key Contact at Carna Biosciences

Emi Yamamoto

Accounting Director, Certified Public Accountant

Company overview

Headquarters	1-5-5, Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, JP
Phone number	+8118886451233
Website	carnabio.com
NAICS	541714
Keywords	Egfr, Residence Time Analysis, % Inhibition Studies, 1Mm Atp Assays, Adp-Glo(Tm) Assays, Activity Assays, Biotinylated Proteins, Cell Cycle Panel, Ic50 Determinations, Kinase Proteins, Lipid Kinases, Mapk Cascade Panel, Mobility Shift Assays, Preincubation, Protein Protein Interaction (Ppi), Raf Dimerization, Serine/Threonine Kinases, Terget Engagement Assays, Tyrosine Kinases, Diacylglycerol Kinases (Dgks)
Founded	2003
Employees	21-50
Socials

Carna Biosciences Email Formats

Carna Biosciences uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 45.6% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	45.6%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	22.3%
{first name}@company.com	john@company.com	15.1%
{first name}{last name}@company.com	johndoe@company.com	9.8%
{first name}_{last name}@company.com	john_doe@company.com	7.2%

About Carna Biosciences

Carna Biosciences, a biotechnology company focusing on kinases as the important targets for the development of drugs to treat a variety of diseases, including cancer, inflammation, and neurological disorders, offers a wide range of kinase protein products all developed and manufactured in-house and assay services with extensive kinase targets for your research and development. Our biochemical assay services are boast of delivering highly reproducible quality data by employing only our in-house kinases which have passed our stringent QC and conducting experiments under the thoroughly managed assay system by skilled hands. Our cell-based assays which investigate your compounds’ binding activities generate reliable data utilizing the well-established Promega’s NanoBRET™ technology. In addition to these kinase products and services, our rich experiences, deep knowledge, and know-how in drug discovery targeting kinases will give you unparalleled support which surely helps accelerate your drug discovery. If you are engaged in kinase inhibitor research and development, Carna Biosciences will be your best support partner.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Director

Employees by Department

Carna Biosciences has 9 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Carna Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2006-02-01	3	N/A

Funding Insights

Number of funding rounds

Carna Biosciences Tech Stack

Discover the technologies and tools that power Carna Biosciences's digital infrastructure, from frameworks to analytics platforms.

Plesk

Hosting panels

Nginx

Reverse proxies

Frequently asked questions

Carna Biosciences is located in 1-5-5, Minatojima-Minamimachi, JP.

You can reach Carna Biosciences at +8118886451233.

Carna Biosciences generates an estimated annual revenue of $19,388,748. This revenue figure reflects the company's market position and business performance in its industry.

Carna Biosciences has an estimated valuation of $62,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Carna Biosciences was founded in 2003, making it 23 years old. The company has established itself as a significant player in its industry over this time.

Carna Biosciences has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Carna Biosciences

Emi Yamamoto

Accounting Director, Certified Public Accountant

4.8

40,000 users